News
-
-
-
PRESS RELEASE
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
Lunai Bioworks launches platform embedding risk intelligence into AI pipelines for faster therapeutic development and biodefense. The solution safeguards against misuse of generative AI -
PRESS RELEASE
Insolvency EVAN Group PLC ISIN: DE000A19L426 / WKN: A19L42 - GÖRG RECHTSANWÄLTEGEMEINSCHAFT
Swiss Merchant Group AG files claim for financial damage due to incorrect insolvency application by law firm GÖRG Rechtsanwälte Gemeinschaft for EVAN Group PLC. Board to stand for election as bondholders' representative -
-
PRESS RELEASE
1933 Industries Closes Repurchase and Cancellation of Convertible Debentures
1933 Industries Inc. closes Debenture Repurchase Agreement, repurchasing $475,000 in principal value for $47,500 CAD, removing outstanding liabilities. Agreement conducted in accordance with trust indenture and securities laws -
-
PRESS RELEASE
Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
Telomir Pharmaceuticals announces new preclinical findings showing Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, potentially restoring cancer cell cycle control and immune surveillance -
PRESS RELEASE
Sky Gold Announces Board of Directors and Advisory Board Additions
Sky Gold Corp. welcomes Danae Voormeij and John Duncan to its Board of Directors and Advisory Board, announces resignation of Aaron McBreairty, sets stock options, and focuses on Evening Star gold project in Nevada's Walker Lane trend -
PRESS RELEASE
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study
Revelation Biosciences reports positive safety and activity data for Gemini in phase 1b PRIME study for CKD patients, showing reduction in inflammatory activity and cellular response normalization
